Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform Pathlight, developer Saga Diagnostics entered a definitive merger agreement under which Roche Holding AG subsidiary Foundation Medicine Inc. will take over the firm in return for up to $595 million in payments.<\/p>\n
BioWorld<\/a> Deals and M&A<\/a> Medical technology<\/a> Diagnostics<\/a> Cancer<\/a> U.S.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Nearly a year after the first U.S. commercial launch of the multicancer molecular residual disease (MRD) detection platform…\n","protected":false},"author":2,"featured_media":58048,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[124],"tags":[8086,2112,8568,1176,32280,9063,32281,29269,29270,134,473,32282,32279,2278],"class_list":{"0":"post-58047","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-roche","8":"tag-bioworld","9":"tag-cancer","10":"tag-deals-and-ma","11":"tag-diagnostics","12":"tag-foundation-medicine-inc","13":"tag-medical-technology","14":"tag-molecular-residual-disease","15":"tag-mrd","16":"tag-pathlight","17":"tag-roche","18":"tag-roche-holding-ag","19":"tag-saga-diagnostics","20":"tag-saga-diagnostics-ab","21":"tag-u-s"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116492163040955680","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/58047","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=58047"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/58047\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/58048"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=58047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=58047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=58047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}